STOCK TITAN
  1. Home
  2. Sec-filings
  3. VRXA
  4. [Form 3] Veraxa Biotech Holding AG Initial Statement of Beneficial Ownership

Veraxa Biotech (VRXA) director reports 5.7M-share stake via Akira Holding AG

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Veraxa Biotech Holding AG director Oliver Rolf Baumann filed an initial Form 3 disclosing a large indirect ownership stake. The filing reports that Akira Holding AG holds 5,723,618 Ordinary Shares, and Baumann may be deemed to beneficially own these shares through his relationship with Akira Holding AG. This is a disclosure of existing holdings rather than a new purchase or sale, giving investors a view of the director’s indirect equity interest.

Positive

  • None.

Negative

  • None.
Insider Baumann Oliver Rolf
Role Director
Type Security Shares Price Value
holding Ordinary Shares -- -- --
Holdings After Transaction: Ordinary Shares — 5,723,618 shares (Indirect, Indirect ownership through Akira Holding AG)
Footnotes (1)
  1. F1. The reported securities are held by Akira Holding AG. The reporting person may be deemed to beneficially own such securities by virtue of their relationship with Akira Holding AG.
Indirect Ordinary Shares 5,723,618 shares Held by Akira Holding AG; Baumann may be deemed beneficial owner
Holding entries 1 entry Transaction summary shows one holding entry and no trades
Net buy/sell shares 0 shares Transaction summary indicates neutral net buy/sell activity
Ordinary Shares financial
"The reported securities are held by Akira Holding AG."
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
Indirect ownership financial
"Indirect ownership through Akira Holding AG"
beneficially own regulatory
"The reporting person may be deemed to beneficially own such securities"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.
Form 3 regulatory
"initial statement of beneficial ownership on Form 3"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding Insider Trading Forms →
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Baumann Oliver Rolf
(Last)(First)(Middle)
TALACKER 35
(Street)
ZURICH8001
(City)(State)(Zip)
SWITZERLAND
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
06/09/2026		3. Issuer Name and Ticker or Trading Symbol
Veraxa Biotech Holding AG [ VRXA ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares5,723,618IIndirect ownership through Akira Holding AG(1)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The reported securities are held by Akira Holding AG. The reporting person may be deemed to beneficially own such securities by virtue of their relationship with Akira Holding AG.
/s/ Oliver R. Baumann06/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR